A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Conditions
Parkinson Disease · Parkinson · Idiopathic Parkinson Disease · Early Parkinson Disease (Early PD) · Parkinson Disease, Idiopathic
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Banner Sun Health Research Institute, Sun City, Arizona, United States
Contact: Principal Investigator (David Shprecher, DO)University of Arkansas, Little Rock, Arkansas, United States
Contact: Principal Investigator (Rohit Dhall, MD)Neuro-Pain Medical Center, Fresno, California, United States
Contact: Principal Investigator (Perminder Bhatia, MD)University of California, Irvine, Irvine, California, United States
Contact: Principal Investigator (Sanaz Attaripour Isfahani, MD)University of California, Los Angeles, Los Angeles, California, United States
Contact: Principal Investigator (Jeff Bronstein, MD, PhD)Esperanza Clinical, Murrieta, California, United States
Contact: Principal Investigator (Michael Ropacki, PhD)Parkinson's Research Centers of America - Palo Alto, Palo Alto, California, United States
Contact: Principal Investigator (Salima Brillman, MD)Sutter Neuroscience Institute, Sacramento, California, United States
Contact: Principal Investigator (Nicklesh Thakur, DO)University of Colorado - Anschutz Medical Campus, Aurora, Colorado, United States
Contact: Principal Investigator (Emily Forbes, DO)Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton, Florida, United States
Contact: Principal Investigator (Stuart Isaacson, MD, FAAN)University of Florida, Gainesville, Florida, United States
Contact: Principal Investigator (Irene Malaty, MD)Neurology One, Orlando, Florida, United States
Contact: Principal Investigator (Ramon L Rodriguez, MD, FAAN)USF Parkinson's & Movement Disorders Clinic, Tampa, Florida, United States
Contact: Principal Investigator (Robert Hauser, MD, MBA, FAAN)Emory University, Atlanta, Georgia, United States
Contact: Principal Investigator (Stewart Factor, DO)Augusta University, Augusta, Georgia, United States
Contact: Principal Investigator (John Morgan, MD, PhD)Northwestern Medical Group, Department of Neurology, Chicago, Illinois, United States
Contact: Principal Investigator (Danielle N Larson, MD)University of Kansas Medical Center, Kansas City, Kansas, United States
Contact: Principal Investigator (Rajesh Pahwa, MD)University of Kentucky, Lexington, Kentucky, United States
Contact: Principal Investigator (John Slevin, MD, MBA)Ochsner Clinic Foundation, New Orleans, Louisiana, United States
Contact: Principal Investigator (David Houghton, MD)University of Maryland, Baltimore, Maryland, United States
Contact: Principal Investigator (Joseph Savitt, MD, PhD)Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Contact: Principal Investigator (Ludy Shih, MD, MMSc)Quest Research Institute, Farmington Hills, Michigan, United States
Contact: Principal Investigator (Aaron Ellenbogen, DO, MPH)Struthers Parkinson Center, Golden Valley, Minnesota, United States
Contact: Principal Investigator (Sotirios Parashos, MD, PhD)Cleveland Clinic, Las Vegas, Nevada, United States
Contact: Principal Investigator (Zoltan Mari, MD)University of New Mexico, Albuquerque, New Mexico, United States
Contact: Principal Investigator (Sarah P Richardson, MD, FAAN)Northwell Health, Great Neck, New York, United States
Contact: Principal Investigator (Ritesh Ramdhani, MD)Icahn School of Medicine at Mount Sinai/Mount Sinai West, New York, New York, United States
Contact: Principal Investigator (Joohi Jimenez-Shahed, MD)Columbia University, New York, New York, United States
Contact: Study coordinator (Columbia Movement Disorders Research) · mdresearch@cumc.columbia.edu · 347-882-4315Contact: Principal Investigator (Sheng-Han Kuo, MD)University of Rochester, Rochester, New York, United States
Contact: Principal Investigator (Christopher Tarolli, MD)University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
Contact: Principal Investigator (Daniel Roque, MD)The Ohio State University, Columbus, Ohio, United States
Contact: Principal Investigator (Ariane Park, MD, MPH)The Movement Disorder Clinic of Oklahoma, Tulsa, Oklahoma, United States
Contact: Principal Investigator (Kevin Klos, MD)Oregon Health & Science University (OHSU), Portland, Oregon, United States
Contact: Principal Investigator (Joseph Quinn, MD)Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Tsao-Wei Liang, MD)Medical University of South Carolina, Charleston, South Carolina, United States
Contact: Principal Investigator (Christine Cooper, MD)Vanderbilt University, Nashville, Tennessee, United States
Contact: Principal Investigator (David Charles, MD)Neurology Consultants of Dallas PA, Dallas, Texas, United States
Contact: Principal Investigator (Nirav Pavasia, MD)Baylor College of Medicine, Houston, Texas, United States
Contact: Principal Investigator (Arjun Tarakad, MD)The University of Texas Health Science Center at Houston, Houston, Texas, United States
Contact: Principal Investigator (Raja Mehanna, MD)Central Texas Neurology Consultants, Round Rock, Texas, United States
Contact: Principal Investigator (Elizabeth Peckham, DO)University of Utah Movement Division, Salt Lake City, Utah, United States
Contact: Principal Investigator (Paolo Moretti, MD)University of Virginia, Charlottesville, Virginia, United States
Contact: Principal Investigator (Binit Shah, MD, FAAN)EvergreenHealth, Kirkland, Washington, United States
Contact: Principal Investigator (Pinky Agarwal, MD, FAAN)Inland Northwest Research, Spokane, Washington, United States
Contact: Principal Investigator (Jason Aldred, MD)Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Contact: Principal Investigator (Karen Blindauer, MD)Rambam Medical Center, Haifa, Israel
Contact: Principal Investigator (Ilana Schlesinger, MD, Prof)Shaare Zedek Medical Center, Jerusalem, Israel
Contact: Principal Investigator (Gilad Yahalom, MD, Prof)Sheba Medical Center, Ramat Gan, Israel
Contact: Principal Investigator (Sharon Hassin, MD, Prof)Tel Aviv Medical Center, Tel Aviv, Israel
Contact: Principal Investigator (Tanya Gurevich, MD, Prof)IRCCS Ospedale San Raffaele (HSR) - Dipartimento Di Neurologia, Milan, Italy
Contact: Principal Investigator (Massimo Filippi, MD, Prof)Universita Degli Studi Della Campania "Luigi Vanvitelli" - Azienda Ospedaliera Universitaria, Naples, Italy
Contact: Principal Investigator (Alessandro Tessitore, MD, PhD)Universita Degli Studi Di Padova - Azienda Ospedaliera Di Padova - Clinica Neurologica, Padua, Italy
Contact: Principal Investigator (Angelo Antonini, MD, PhD, Prof)Azienda Ospedaliero Universitaria Pisana - Stabilimento Ospedaliero Di Santa Chiara, Pisa, Italy
Contact: Principal Investigator (Roberta Ceravolo, MD, Prof)Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - San Raffaele Pisana, Rome, Italy
Contact: Principal Investigator (Fabrizio Stocchi, MD, PhD)Fondazione Policilinico Universitario A Gemelli IRCCS, Rome, Italy
Contact: Study coordinator (Flavia Torlizzi) · flavia.torlizzi@policlinicogemelli.it · +39 0630155633Contact: Principal Investigator (Anna Rita Bentivoglio, MD, PhD)Centrum Medyczne Neuromed, Bydgoszcz, Poland
Contact: Principal Investigator (Pawel Lisewski, MD)NZOZ Wielospecjalistyczna Poradnia Lekarska Synapsis Lech Szczechowski, Katowice, Poland
Contact: Principal Investigator (Katarzyna Smilowska, MD, PhD)Pro Life Medica Sp. z o. o. ETA Lublin, Lublin, Poland
Contact: Principal Investigator (Dominika Tomaka, MD)Insula Badania Sp. Z o.o., Warsaw, Poland
Contact: Principal Investigator (Marta Jethon, MD)Policlinica Gipuzkoa - Centro de Investigacion Parkinson (CIP), San Sebastián, Donostia, Spain
Contact: Principal Investigator (Gurutz Linazasoro, MD)Instituto de Investigacion Sanitaria Biocruces Bizkaia - Hospital Universitario Cruces, Barakaldo, Spain
Contact: Principal Investigator (Juan Carlos Gomez Esteban, MD, PhD)Hospital Universitari Vall d'Hebron, Barcelona, Spain
Contact: Study coordinator (Jorge Hernandez Vara, MD) · jorge.hernandez@vallhebron.cat · +34 934893000Contact: Principal Investigator (Jorge Hernandez Vara, MD)Hospital Clinic de Barcelona (Hospital Clinic i Provincial) - Barnaclinic S.A., Barcelona, Spain
Contact: Principal Investigator (Alicia Garrido, Pla)Universidad Autonoma de Madrid (UAM) - Hospital Universitario de La Princesa, Madrid, Spain
Contact: Principal Investigator (Lydia Lopez Manzanares, MD)Hospital Universitario HM Puerta del Sur, Móstoles, Spain
Contact: Principal Investigator (Michele Matarazzo, MD)Hospital Universitario Virgen del Rocio (HUVR) - Instituto de Biomedicina de Sevilla (IBIS), Seville, Spain
Contact: Principal Investigator (Pablo Mir, MD)St George's Hospital, University of London, London, England, United Kingdom
Contact: Principal Investigator (Francesca Morgante, MD)University College London Hospitals NHS Foundation Trust, London, England, United Kingdom
Contact: Principal Investigator (Huw Morris, MD, PhD)Clinical Aging Research Unit, Newcastle University, Newcastle upon Tyne, England, United Kingdom
Contact: Study coordinator (Nicola Pavese, MD, PhD, FRCP, FEAN) · nicola.pavese@ncl.ac.uk · +44 0191 2081264Contact: Principal Investigator (Nicola Pavese, MD, PhD, FRCP, FEAN)Ninewells Hospital and Medical School - NHS Tayside, Dundee, Scotland, United Kingdom
Contact: Principal Investigator (Esther Sammler, MD)
Study leads
Fatta B Nahab, MD, FAAN FANA
Principal Investigator
Neuron23 Inc.